Canada markets closed

IGC Pharma, Inc. (IGC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4580+0.0280 (+6.51%)
At close: 04:00PM EDT
0.4800 +0.02 (+4.80%)
After hours: 07:52PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 30.60M
Enterprise Value 29.60M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)21.11
Price/Book (mrq)3.38
Enterprise Value/Revenue 24.34
Enterprise Value/EBITDA -2.68

Trading Information

Stock Price History

Beta (5Y Monthly) 1.77
52-Week Change 335.29%
S&P500 52-Week Change 322.36%
52 Week High 30.9100
52 Week Low 30.2500
50-Day Moving Average 30.4122
200-Day Moving Average 30.3444

Share Statistics

Avg Vol (3 month) 3915.23k
Avg Vol (10 day) 31.34M
Shares Outstanding 566.81M
Implied Shares Outstanding 666.81M
Float 856.96M
% Held by Insiders 120.44%
% Held by Institutions 13.71%
Shares Short (Apr 15, 2024) 4768.12k
Short Ratio (Apr 15, 2024) 40.53
Short % of Float (Apr 15, 2024) 41.22%
Short % of Shares Outstanding (Apr 15, 2024) 41.15%
Shares Short (prior month Mar 15, 2024) 4848.51k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Apr 19, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,469.61%

Management Effectiveness

Return on Assets (ttm)-44.01%
Return on Equity (ttm)-103.36%

Income Statement

Revenue (ttm)1.22M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-38.60%
Gross Profit (ttm)N/A
EBITDA -10.4M
Net Income Avi to Common (ttm)-14.14M
Diluted EPS (ttm)-0.2600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.38M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)380k
Total Debt/Equity (mrq)4.20%
Current Ratio (mrq)1.85
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-6.19M
Levered Free Cash Flow (ttm)-1.91M